Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21.
Saved in:
| Title: | Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21. |
|---|---|
| Authors: | Lim S; Alfred Health, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Reynolds J; Alfred Health, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Quach H; St Vincent's Hospital, Melbourne, Victoria, Australia.; University of Melbourne, Melbourne, Victoria, Australia., Hutchinson A; Royal Hobart Hospital, Hobart, Tasmania, Australia., Kerridge I; Royal North Shore Hospital, Sydney, New South Wales, Australia., Janowski W; Calvary Mater Newcastle, Waratah, New South Wales, Australia., Bergin K; Alfred Health, Melbourne, Victoria, Australia., Spencer A; Alfred Health, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia. |
| Source: | British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 900-914. Date of Electronic Publication: 2024 Jun 08. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.19578 |
